13F filer · CIK 1230765
RICE HALL JAMES & ASSOCIATES, LLC
San Diego, CA · filing since Q2 2013 · last filing Aug 7, 2026
Reported value
$2.1B
+$258.9M vs prior
Positions
240
New / sold out
14 / 17
Added / reduced
110 / 101
Turnover
10.2%
buys $200.6M · sells $197.2M
Top-10 weight
24.1%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | ASCENDIS PHARMA A/S | +148,644 | – | +$39.6M |
| New | OSHKOSH CORP | +106,011 | – | +$16.3M |
| Added | UPWORK INC | +1,468,638 | +112.3% | +$12.3M |
| Added | TETRA TECHNOLOGIES INC DEL | +1,028,089 | +2582.0% | +$11.6M |
| Added | BIOMARIN PHARMACEUTICAL INC | +143,565 | +137.2% | +$8.2M |
| Added | PRESTIGE CONSMR HEALTHCARE I | +168,070 | +32.2% | +$7.9M |
| New | PAR TECHNOLOGY CORP | +378,930 | – | +$6.6M |
| New | SHOALS TECHNOLOGIES GROUP IN | +650,383 | – | +$6.4M |
| New | ALPHATEC HLDGS INC | +657,864 | – | +$5.7M |
| Added | VIRIDIAN THERAPEUTICS INC | +277,295 | +30.9% | +$5.1M |
114 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | ASCENDIS PHARMA A/S | -148,386 | -100.0% | $-33.9M |
| Reduced | AEHR TEST SYS | -184,706 | -67.8% | $-17.7M |
| Reduced | CEVA INC | -321,600 | -76.7% | $-15.2M |
| Sold out | AMICUS THERAPEUTIC | -770,711 | -100.0% | $-11.1M |
| Reduced | FABRINET | -18,238 | -17.2% | $-10.3M |
| Reduced | CHART INDS INC | -35,141 | -48.3% | $-7.3M |
| Sold out | SOLENO THERAPEUTICS INC | -206,147 | -100.0% | $-6.9M |
| Reduced | APPLIED OPTOELECTRONICS INC | -42,549 | -43.3% | $-6.3M |
| Reduced | ICHOR HOLDINGS | -50,118 | -32.5% | $-5.6M |
| Reduced | CLEAR SECURE INC | -92,070 | -16.0% | $-5.1M |
108 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | LIGAND PHARMACEUTICALS INCCOM NEW | 270,052 | $85.4M | 4.15% |
| 2 | ACI WORLDWIDE INCCOM | 1,006,595 | $50.6M | 2.46% |
| 3 | ARLO TECHNOLOGIES INCCOM | 3,732,962 | $50.3M | 2.45% |
| 4 | FABRINETSHS | 87,577 | $49.2M | 2.40% |
| 5 | ESTABLISHMENT LABS HLDGS INCCOM | 560,935 | $48.1M | 2.34% |
| 6 | XPO INCCOM | 224,878 | $46.2M | 2.25% |
| 7 | ZIFF DAVIS INCCOM | 821,496 | $43.0M | 2.09% |
| 8 | SHIFT4 PMTS INCCL A | 874,492 | $42.5M | 2.07% |
| 9 | KINIKSA PHARMACEUTICALS INTLORD SHS CL A | 624,928 | $40.0M | 1.95% |
| 10 | ASCENDIS PHARMA A/SORD SHS | 148,644 | $39.6M | 1.93% |
230 more rows. Subscribe for $29/month to see every row, download the data and use the API.